It has been a strong week for the UK’s growth companies, with the AIM All-Share—widely seen as the benchmark for smaller-cap stocks—rising 4.5% as investors looked through geopolitical uncertainty and
ImmuPharma advances P140 partnering strategy following £6.5m raise
ImmuPharma PLC (AIM: IMM) said it is actively progressing partnering discussions for its lead autoimmune platform, P140, which remains its primary strategic focus for 2026.
RNS Hotlist with Zak Mir: ZEN, LST, THX, RMR, GSCU, ASTR, IMM, SWC, SEEN, MKA, ITM, AVCT, EGT, MBO & WSBN
Zenith Energy Ltd. (ZEN) announced the appointment of Mr. Charles Michel, the former President of the European Council (2019-2024) and former Prime Minister of Belgium (2014-2019), to further strengthen the legal
Share Talk Weekly Stock Market News Review, Sunday 29th March 2026
The AIM All-Share slipped slightly on the week and is now down around 7% year-to-date, underlining the pressure on smaller companies. In contrast, the FTSE 100 closed the week at 9,967, slipping just 5
RNS Hotlist with Zak Mir: IMM, KEN, 80M, GROC, EOG, HREE, MWE, 88E & ROAD
ImmuPharma PLC (IMM), the specialist drug discovery and development company, provided an update on its auto-immune technology platform program, P140. IMM said “The receipt of the first Combined Search and Examination
ImmuPharma PLC advances P140 talks as new data strengthens programme
ImmuPharma PLC is stepping up efforts to secure a licensing deal for its P140 autoimmune platform, with discussions underway with multiple potential partners under confidentiality agreements.
Six Biotechs to Watch in 2026: Breakthroughs, Setbacks, and Big Turning Points Ahead
The biotechnology market has delivered a mixed landscape in 2025, shaped by shifting investor sentiment, ongoing regulatory pressures, and the continued search for differentiated clinical assets. Against this backdrop several
Six Biotechs to Watch in 2026: Breakthroughs, Setbacks, and Big Turning Points Ahead
The biotechnology market has delivered a mixed landscape in 2025, shaped by shifting investor sentiment, ongoing regulatory pressures, and the continued search for differentiated clinical assets. Against this backdrop several
RNS Hotlist with Zak Mir: JAN, WCAP, KRPZ, TRLS, OPTI, UPL, UFO, ROQ, MWE, IMM & ANA
Jangada Mines Plc (JAN), a Brazil-focused natural resource development company, announced the appointment of Hugo de Salis to the Board as a Non-Executive Director with immediate effect.
Share Talk Weekly Stock Market News Review, Sunday 9th November 2025
London’s FTSE 100 closed at its lowest level in almost two weeks on Friday, dragged lower by steep losses in property and travel stocks. The blue-chip index ended 53 points,
The Small-Cap Rebuild: 2025 marks a quiet resurgence for EPP, IMM, TAP, ALRT, GEO and CDL
AIMs & LSE’s smaller end often gets dismissed as a market of fading stories and failed pivots, yet 2025 has quietly been a year of reinvention.
Share Talk Weekly Stock Market News Review, Sunday 2nd November 2025
UK stock markets closed lower on Friday, easing back after a record-breaking October rally as investors adopted a more cautious stance ahead of the Bank of England’s monetary policy decision and the Government’s Budget this month.